Antisense oligonucleotides PLGA/PEG microparticles
Latest Information Update: 12 Nov 2002
At a glance
- Originator Nonindustrial source
- Class
- Mechanism of Action Immunomodulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Glioblastoma
Most Recent Events
- 24 Nov 2000 Preclinical development for Glioblastoma in USA (Unknown route)